Recombinant Human Platelet–Derived Growth Factor BB in Combination With a Beta-Tricalcium Phosphate (rhPDGF-BB/β-TCP)-Collagen Matrix as an Alternative to Autograft

Abstract

Background:

Joint arthrodesis often employs autograft to promote union; graft harvesting can lead to perioperative morbidity. A Canadian randomized controlled trial (RCT) demonstrated that recombinant human platelet–derived growth factor BB homodimer (rhPDGF-BB) combined with beta-tricalcium phosphate (β-TCP)-collagen was a safe, effective alternative to autograft. This multicenter North American RCT compared the safety and efficacy of rhPDGF-BB/β-TCP-collagen with autograft for ankle and hindfoot fusion. Subclassification using propensity scores (PS) incorporated patients from previous trials for enhanced statistical power for noninferiority testing and broader review of treatments.

Methods:

Patients requiring ankle or hindfoot arthrodesis and supplemental bone graft were treated with rhPDGF-BB/β-TCP-collagen (n = 69) or autograft (n = 35). Outcomes included joint fusion on computed tomography (24 weeks), clinical healing status, visual analog scale (VAS) pain, Short-Form 12 (SF-12), American Orthopaedic Foot & Ankle Society (AOFAS) Ankle-Hindfoot Scale, and Foot Function Index (FFI) scores over 52 weeks. PS methodology addressed potential selection bias arising from pooling data among these patients and 2 previous RCTs with similar inclusion criteria, surgical techniques, graft harvest techniques, and outcomes. All 132 rhPDGF-BB/β-TCP-collagen–treated patients and 167 of 189 candidate autograft-treated controls were selected for comparison by an independent statistician blinded to outcomes.

Results:

In the PS subclassification, 68.1% treatment patients and 68.4% controls achieved >50% osseous bridging at fusion sites. Clinical healing status was achieved in 84.8% of treated patients and 90.7% of controls at 52 weeks. Clinical, functional, and quality of life results demonstrated noninferiority of rhPDGF-BB/β-TCP-collagen to autograft. Safety-related outcomes were equivalent.

Conclusion:

PS subclassification analysis of 3 RCTs demonstrated that rhPDGF-BB/β-TCP-collagen was as effective as autograft for ankle and hindfoot fusions, with less pain and morbidity than treatment with autograft.

Level of Evidence:

Level I, prospective randomized study.

Keywords

ankle fusion autogeneous bone graft collagen hindfoot fusion nonunion platelet-derived growth factor rhPDGF-BB randomized controlled trial propensity score cohort analysis

Get full access to this article

View all access options for this article.

References

Alvarez

Kantarjian

Cortes

JE.

Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81(9):1241-1257.

Arrington

Smith

Chambers

Bucknell

Davino

NA.

Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300-309.

Budiman-Mak

Conrad

Roach

KE.

The Foot Function Index: a measure of foot pain and disability. J Clin Epidemiol. 1991;44(6):561-570.

Chiodo

Hahne

Wilson

Glowacki

Histological differences in iliac and tibial bone graft. Foot Ankle Int. 2010;31(5):418-422.

Coughlin

Grimes

Traughber

Jones

CP.

Comparison of radiographs and CT scans in the prospective evaluation of the fusion of hindfoot arthrodesis. Foot Ankle Int. 2006;27(10):780-787.

Daniels

DiGiovanni

Lau

Wing

Younger

Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses. Foot Ankle Int. 2010;31(6):473-479.

Daniels

Younger

Penner

et al. Prospective randomized controlled trial of hindfoot and ankle fusions treated with rhPDGF-BB in combination with a beta-TCP-collagen matrix. Foot Ankle Int. 2015;36(7):739-748.

DeOrio

Farber

DC.

Morbidity associated with anterior iliac crest bone grafting in foot and ankle surgery. Foot Ankle Int. 2005;26(2):147-151.

DiGiovanni

Baumhauer

Lin

et al. Prospective, randomized, multi-center feasibility trial of rhPDGF-BB versus autologous bone graft in a foot and ankle fusion model. Foot Ankle Int. 2011;32(4):344-354.

10.

DiGiovanni

Lin

Baumhauer

et al. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/beta-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013;95(13):1184-1192.

11.

Dorsey

Liu

Roberts

Kile

TA.

Correlation of arthrodesis stability with degree of joint fusion on MDCT. AJR Am J Roentgenol. 2009;192(2):496-499.

12.

Easley

Trnka

Schon

Myerson

MS.

Isolated subtalar arthrodesis. J Bone Joint Surg Am. 2000;82(5):613-624.

13.

Fiedler

Roederer

Guenther

Brenner

RE.

BMP-2, BMP-4 and PDGF-BB stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem. 2002;87(3):305-312.

14.

Frey

Halikus

Vu-Rose

Ebramzadeh

A review of ankle arthrodesis: predisposing factors to nonunion. Foot Ankle Int. 1994;15(11):581-584.

15.

Frohberg

Mazock

JB.

A review of morbidity associated with bone harvest from the proximal tibial metaphysis. Mund Kiefer Gesichtschir. 2005;9(2):63-65.

16.

Gandhi

Salmon

Zhao

Lambert

Gore

Conrad

Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clin Ther. 2001;23(7):1080-1098.

17.

Garrett

AD.

Therapeutic equivalence: fallacies and falsification. Stat Med. 2003;22(5):741-762.

18.

Glazebrook

Beasley

Daniels

et al. Establishing the relationship between clinical outcome and extent of osseous bridging between computed tomography assessment in isolated hindfoot and ankle fusions. Foot Ankle Int. 2013;34(12):1612-1618.

19.

Glazebrook

Daniels

Younger

et al. Comparison of health-related quality of life between patients with end-stage ankle and hip arthrosis. J Bone Joint Surg Am. 2008;90(3):499-505.

20.

Goh

Bin Abd Razak

Tay

et al. Unicompartmental knee arthroplasty achieves greater flexion with no difference in functional outcome, quality of life, and satisfaction vs total knee arthroplasty in patients younger than 55 years. A propensity score-matched cohort analysis. J Arthroplasty. 2018;33(2):355-361.

21.

Haddad

Coetzee

Estok

et al. Intermediate and long-term outcomes of total ankle arthroplasty and ankle arthrodesis. A systematic review of the literature. J Bone Joint Surg Am. 2007;89(9):1899-1905.

22.

Hollinger

Hart

Hirsch

Lynch

Friedlaender

GE.

Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am. 2008;90(Suppl 1):48-54.

23.

Hollinger

Onikepe

MacKrell

et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalciumphosphate/collagen matrix. J Orthop Res. 2008;26(1):83-90.

24.

Imbens

Rubin

DB.

Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction. New York: Cambridge University Press; 2015.

25.

Kim

Koh

Choi

Lee

Differences in patient-reported outcomes between unicompartmental and total knee arthroplasties: a propensity score-matched analysis. J Arthroplasty. 2017;32(5):1453-1459.

26.

Kirmeier

Payer

Lorenzoni

et al. Harvesting of cancellous bone from the proximal tibia under local anesthesia: donor site morbidity and patient experience. J Oral Maxillofac Surg. 2007;65(11):2235-2241.

27.

Kitaoka

Alexander

Adelaar

et al. Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int. 1994;15(7):349-353.

28.

Krause

Younger

Baumhauer

et al. Clinical outcomes of nonunions of hindfoot and ankle fusions. J Bone Joint Surg Am. 2016;98(23):2006-2016.

29.

Lynch

Williams

Polson

et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontal. 1989;16:545-548.

30.

Maislin

Rubin

DB.

Design of non-randomized medical device trials based on sub-classification using propensity score quintiles. Paper presented at: Proceedings of the Joint Statistical Meetings; July 31-August 5, 2010; Vancouver, BC, Canada. https://www.slideshare.net/gmaislin/propensity-scores-in-medical-device-trials. Accessed May 13, 2019.

31.

Myeroff

Archdeacon

Autogenous bone graft: donor sites and techniques. J Bone Joint Surg Am. 2011;93(23):2227-2236.

32.

Rosenbaum

Rubin

DB.

The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.

33.

Rubin

DB.

Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3-4):169-188.

34.

Rubin

DB.

For objective causal inference, design trumps analysis. Ann Appl Stat. 2008;2(3):808-840.

35.

Thevendran

Younger

Pinney

Current concepts review: risk factors for nonunions in foot and ankle arthrodeses. Foot Ankle Int. 2012;33(11):1031-1040.

36.

Ware

Jr Kosinski

Turner-Bowker

Gandek

User’s Manual for the SF-12v2 Health Survey. Boston: QualityMetric Inc; 2009.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.19 MB

0.33 MB